Showing results (161-170 of 191) with videos related to

Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysisLauren E Abrey, Craig H Moskowitz, Warren P Mason, et al.
Blood Advances|December 3, 2024
Anxiety and depression in patients with histiocytic neoplasms and their associated clinical featuresAnne S Reiner, Yesne Alici, Denise D Correa, et al.
Mayo Clinic Proceedings|May 4, 2010
Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, MinnesotaDaniel D Correa de Sa, Imad M Tleyjeh, Nandan S Anavekar, et al.
Neurosurgery|September 12, 2000
An integrated functional magnetic resonance imaging procedure for preoperative mapping of cortical areas associated with tactile, motor, language, and visual functionsJ Hirsch, M I Ruge, K H Kim, et al.
Journal of Neurotrauma|May 1, 1996
Alteration of cyclosporin-A pharmacokinetics after experimental spinal cord injuryA Ibarra, G Guízar-Sahagún, D Correa, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1997
Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonistA I Sacaan, R T Reid, E M Santori, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 26, 2003
Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challengeDaniel S Lorrain, Hervé Schaffhauser, Una C Campbell, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 15, 2009
Pharmacological characterization of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103), a novel selective 5-lipoxygenase-activating protein inhibitor that reduces acute and chronic inflammationDaniel S Lorrain, Gretchen Bain, Lucia D Correa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcomePatrick G Morris, Denise D Correa, Joachim Yahalom, et al.
The American Journal of Tropical Medicine and Hygiene|September 25, 1999
Prevalence and risk of cysticercosis and taeniasis in an urban population of soldiers and their relativesM L García-García, M Torres, D Correa, et al.
Pageof 20